Featured projects

  • Dissecting the role of SNX13 in cholesterol transport: Implications for Niemann-Pick Type C disease.

    Principal investigator: Francesc Tebar Ramon, Albert Lu López.
    Funder: Ara Parseghian Medical Research Fund at Notre Dame.
    Duration: 01/10/2025 - 30/09/2026
  • Análisis integrativo de la resistencia dinámica a la muerte celular en tumores del estroma gastrointestinal (INTGIST)

    Principal investigator: Joan Montero Boronat.
    Funder: Ministerio de Ciencia e Innovación.
    Code: PID2024-159425OB-I00.
    Duration: 01/09/2025 - 31/08/2029
  • Role of KRAS and its phosphorylation in epithelial organization, invasion and exosome biogenesis of colorectal cancer cells

    Principal investigator: Albert Lu López, Neus Agell Jane.
    Funder: Ministerio de Ciencia e Innovación.
    Code: PID2022-138728OB-I00.
    Duration: 01/09/2023 - 31/08/2026
  • Integrative analysis in dynamic resistance in non-responding relapsed pediàtric acute lymphoblastic leukemia patients

    Principal investigator: Joan Montero Boronat.
    Funder: Deutsche José Carreras Leukämie-Stiftung (DJCLS).
    Duration: 01/07/2023 - 30/06/2026
  • Study of novel biomarkers for CIN-targeted breast cancer therapy (CALIBRATE)

    Principal investigator: Caroline Mauvezin.
    Funder: Asociación Española Contra el Cáncer.
    Duration: 01/12/2022 - 30/11/2025
  • Centralization of pathological diagnosis and implementation of precision medicine strategies in sarcoma.

    Funder: Asociación Española Contra el Cáncer (AECC).
    Duration: 01/12/2022 - 31/12/2027
  • Role of Annexin A6 in cholesterol transport through membrane contact sites (MCS) and exosome biology

    Principal investigator: Carles Enrich Bastus, Carles Rentero Alfonso.
    Funder: Ministerio de Ciencia e Innovación.
    Duration: 01/09/2021 - 31/03/2025
  • LRRK2 kinase and glucocerebrosidase (GCase) activity-mediated regulation of a lysosomal phospholipid, bis(monoacylglycerol)-phosphate (BMP)

    Principal investigator: Albert Lu López.
    Funder: The Michael J Fox Foundation for Parkinson’s Research.
    Code: MJFF-019043.
    Duration: 01/01/2021 - 01/01/2023